This document provides a summary of a report on the global healthcare cold chain logistics market from 2016-2020. It discusses trends in temperature sensitive healthcare products that require cold chain logistics and forecasts growth in related markets and services. The report analyzes the market size and segments for clinical trials materials, vaccines, and biopharmaceuticals. It also examines regional trends and profiles major industry players.

1. Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
imarc
www.imarcgroup.com
Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)
2015 Edition

2. About IMARC Group
The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and
market research worldwide. We partner with clients in all sectors and regions to identify their highest-value
opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business
leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel
processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close
cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive
advantage, build more proficient organizations, and secure lasting results.
2

3. Report Description and Highlights
Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)
IMARC Group has launched a comprehensive report on the global healthcare cold chain logistics market.
The research presents an exhaustive insight on various aspects in the packaging, storage and
transportation of temperature sensitive healthcare products. This includes market size, trends,
segments, geographies, drivers, challenges, logistic requirements, trade, key players, regulations, etc.
IMARC Group, one of the world’s leading research and advisory firms, finds that the total size of the
healthcare cold chain logistic services market is expected to expand from its current figures of US$ 8.5
billion to nearly US$ 13.4 billion by 2020. IMARC’s new report entitled “Global Healthcare Cold Chain
Logistics Market Report & Forecast (2016-2020)” , which is the fourth edition of our highly acclaimed
publication, provides a comprehensive insight into the logistic opportunities in the global healthcare
market. The study, that has been undertaken using both desk based and qualitative primary market
research, has analyzed three key aspects of the global healthcare cold chain logistics market.
The first aspect involves an in-depth understanding on the global healthcare cold chain distribution
process and logistic requirements for various temperature sensitive healthcare products. The second
aspect involves the quantification of the global healthcare cold chain logistic services market and a
comprehensive evaluation of its various segments.
3

4. Report Description and Highlights
The third aspect involves the quantification of the global market for temperature sensitive healthcare
products into three major classes and evaluation of the current and future opportunities in each of these
classes.
What we have achieved in this report?
Understanding the Healthcare Cold Chain Distribution Process
Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages
• Understanding the cold chain requirements for various temperature sensitive healthcare products and
the impact of temperature excursions
• Understanding the key steps required in the setting and organization of an efficient cold chain
distribution process
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold
chain transportation
4

5. Report Description and Highlights
Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market
Focus of the analysis:
• Analyzing and evaluating the global healthcare cold chain logistic services market
• Analyzing and evaluating the global healthcare cold chain logistic services market by product
o Biopharmaceuticals
o Vaccines
o Clinical trials
• Analyzing and evaluating the global healthcare cold chain logistic services by segment
o Transportation
o Packaging
o Instrumentation
• Analyzing and evaluating the global healthcare cold chain logistic services market by Region
o North America
o Europe
o Asia Pacific
5

6. Report Description and Highlights
Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:
Classes Covered: Biopharmaceuticals, Vaccines and Clinical Trial Materials
Focus of the Analysis in Each Class:
• Drivers and challenges
• Historical and future sales trends
• Logistic requirements
• Impact of temperature excursions
• Opportunities in cold chain services
Information Sources:
• Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company
websites and reports, books, trade journals, magazines, white papers, industry portals, government
sources and access to more than 4000 paid databases.
6

7. Report Description and Highlights
Table of Contents
1 Research Methodology & Market Definitions
2 Executive Summary
3 Current Trends in the Global Healthcare Cold Chain Logistic Services Market
3.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.3 Outsourcing Trends in Research and Manufacturing Have Increased Logistic Demands
3.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.5 Cost is Not Always the Most Important Driver in Supplier Decisions
4 Healthcare Cold Chain Logistics: How Does It Operate?
4.1 Cold Chain Packaging and Transportation Methods
4.1.1 Dry Ice
4.1.2 Liquid Nitrogen
4.1.3 Gel Packs
4.2 Setting Up a Cold Chain
4.2.1 Initial Considerations
4.2.2 Choosing the Correct Model
4.2.3 Regulatory/Custom Clearance
4.2.4 Final Stages
7

8. Report Description and Highlights
4.2.5 Quality Assurance
4.1 Modeling the Cost of Cold Chain Packaging and Transportation
5 The Healthcare Cold Chain Logistic Services Market
5.1 Current Market Trends
5.2 Market Breakup by Product
5.2.1 Clinical Trial Materials
5.2.2 Vaccines
5.2.3 Biopharmaceuticals
5.3 Market Breakup by Segment
5.3.1 Transportation
5.3.1.1 Current and Historical Market Trends
5.3.1.2 Market Breakup by Transportation Type
5.3.1.3 Market Forecast
5.3.2 Packaging
5.3.2.1 Current and Historical Market Trends
5.3.2.2 Market Breakup by Packaging Type
5.3.2.3 Market Forecast
5.3.3 Instrumentation
5.3.3.1 Current and Historical Market Trends
5.3.3.1 Market Breakup by Instrumentation Type
5.3.3.1 Market Forecast
5.4 Market Breakup by Region
8

9. Report Description and Highlights
5.4.1 North America
5.4.2 Europe
5.4.3 Asia Pacific
5.4.4 Rest of the World
6 The Global Healthcare Cold Chain Products Market
6.1 Historical, Current and Future Market Trends
6.2 Market Segments
6.2.1 Biopharmaceuticals
6.2.1.1 Historical, Current and Future Market Trends
6.2.1.2 Cold Chain Requirements for Biopharmaceuticals
6.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
6.2.2 Vaccines
6.2.2.1 Historical, Current and Future Market Trends
6.2.2.2 Cold Chain Requirements for Vaccines
6.2.2.3 Cold Chain Opportunities for Vaccines
6.2.3 Clinical Trial Materials
6.2.3.1 Historical, Current and Future Market Trends
6.2.3.2 Cold Chain Requirements for Clinical Trial Materials
6.2.3.3 Cold Chain Opportunities for Clinical Trial Materials
7 Challenges in the Healthcare Cold Chain Logistics Market
9

10. Report Description and Highlights
8 Global Trade of Temperature Sensitive Healthcare Products
8.1 Global Exports of Temperature Sensitive Healthcare Products
8.1.1 Current and Historical Trends
8.1.2 Major Exporting Countries
8.2 Global Imports of Temperature Sensitive Healthcare Products
8.2.1 Current and Historical Trends
8.2.2 Major Importing Countries
9 Key Company Profiles
9.1 World Courier
9.2 DHL
9.3 Fedex
9.4 United Parcel Service
9.4 United Parcel Service
9.5 Kuehne and Nagel
9.6 Cavalier Logistics
9.7 DB Schenker
9.8 Life ConEx
9.9 American Airlines Cargo
9.10 Continental Air Cargo
9.11 Marken
10

11. Report Description and Highlights
List of Figures
Figure 3 1: Global - Healthcare Cold & Non Cold Chain Products Market (in Billion US$), 2007 - 2014
Figure 3 2: Global - Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2015 - 2020
Figure 3 3: Global - Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
Figure 3 4: Global - Contract Research & Manufacturing Market (in Billion US$), 2009 - 2014
Figure 3 5: Global - Contract Research & Manufacturing Market Forecast (in Billion US$), 2015 – 2020
Figure 3 6: Estimated Costs incurred in Various Pharmaceutical Operations
Figure 4 1: A Typical Drug Supply Chain from the Manufacturer to the End User
Figure 5 1: Global - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2004 - 2014
Figure 5 2: Global - Healthcare Non Cold Chain Logistic Services Market (in Billion US$), 2004 - 2014
Figure 5 3: Global - Healthcare Logistic Services Market, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2014
Figure 5 4: Global - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 5: Global - Healthcare Non Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 6: Global - Healthcare Logistic Services Market Forecast, Share of Cold-Chain and Non Cold-Chain Services*, (in %),
2020
Figure 5 7: Global - Healthcare Cold Chain Logistic Services Market by Product (in %), 2014 and 2020
Figure 5 8: Global - Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2004 - 2014
Figure 5 9: Global - Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 10: Global - Vaccines Cold Chain Logistic Services Market (in Billion US$), 2004 - 2014
11

12. Report Description and Highlights
Figure 5 11: Global - Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 12: Global - Biopharmaceuticals Cold Chain Logistic Services Market (in Billion US$), 2004 - 2014
Figure 5 13: Global - Biopharmaceuticals Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 14: Global - Healthcare Cold Chain Logistic Services Market by Segment (in %), 2014 and 2020
Figure 5 15: Global - Healthcare Cold Chain Transportation Services Market (in Billion US$), 2004 - 2014
Figure 5 16: Global - Healthcare Cold Chain Transportation Services Market: Breakup by Transportation Mode (in %), 2014
Figure 5 17: Global - Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 18: Global - Healthcare Cold Chain Packaging Services Market (in Billion US$), 2004 - 2014
Figure 5 19: Global - Healthcare Cold Chain Packaging Services Market: Breakup by Packaging Type (in %), 2014
Figure 5 20: Global - Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 21: Global - Healthcare Cold Chain Instrumentation Services Market (in Billion US$), 2004 - 2014
Figure 5 22: Global - Healthcare Cold Chain Instrumentation Services Market: Breakup by Instrumentation Type (in %),
2014
Figure 5 23: Global - Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 24: Global - Healthcare Cold Chain Logistic Spending by Region (in US$ Billion), 2012, 2014, 2016, 2018 and 2020
Figure 5 25: North America - Healthcare Cold Chain Logistic Services Market - (in Billion US$), 2008 - 2014
Figure 5 26: North America - Healthcare Cold Chain Logistic Services Market Forecast - (in Billion US$), 2015 - 2020
Figure 5 27: Europe - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2014
Figure 5 28: Europe - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 29: Asia Pacific - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 - 2014
Figure 5 30: Asia Pacific - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
12

13. Report Description and Highlights
Figure 5 30: Asia Pacific - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
Figure 5 31: Rest of the World - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 - 2014
Figure 5 32: Rest of the World - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 - 2020
Figure 6 1: Global - Healthcare Cold Chain Products Market - Breakup by Segment (in %), 2007 - 2014
Figure 6 2: Global - Healthcare Cold Chain Products Market Forecast - Breakup by Segment (in %), 2015 - 2020
Figure 6 3: Global - Biopharmaceutical Market (in Billion US$), 2007 - 2014
Figure 6 4: Global - Biopharmaceutical Market Forecast (in Billion US$), 2015 - 2020
Figure 6 5: Global - Biosimilar Sales and Forecast (in Million US$), 2014 and 2020
Figure 6 6: Global - Share of Biopharmaceutical Manufacturers Outsourcing Some Production to Contract Manufacturers
(in %), 2006 and 2011
Figure 6 7: Global - Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2011 - 2014
Figure 6 8: Global - Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2015 - 2020
Figure 6 9: Global - Vaccine Market (in Billion US$), 2007 - 2014
Figure 6 10: Global - Vaccine Market Forecast (in Billion US$), 2015 – 2020
Figure 6 11: Global - Vaccine Production Volume by Region (in %), 2008*
Figure 6 12: Europe - Vaccine Export Volume by Region (in %), 2008*
Figure 6 13: Global - Clinical Trials Market (in Billion US$), 2007 - 2014
Figure 6 14: Global - Clinical Trials Market - Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2009
- 2014
Figure 6 15: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982 - 2009
Figure 6 16: Global - Clinical Trials Market Forecast (in Billion US$), 2015 - 2020
13

14. Report Description and Highlights
Figure 6 17: Global - Clinical Trials Market Forecast - Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion
US$), 2015 - 2020
Figure 6 18: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty Global
Pharmaceutical Companies*
Figure 6 19: Global - Breakup of Biopharmaceuticals and Small Molecule Drugs in Preclinical & Clinical trials, (in %), 2009
Figure 6 20: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009
Figure 7 1: Financing Sources and Gaps (in %), 2008 - 2010
Figure 8 1: Global - Exports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007-2013
Figure 8 2: Global - Exports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007 -
2013
Figure 8 3: Global - Exports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons),
2007 - 2013
Figure 8 4: Global - Exports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic,
Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007 – 2013
Figure 8 5: Global - Exports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007 - 2013
Figure 8 6 : Global - Exports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007 -
2013
Figure 8 7: Global - Exports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons),
2007 - 2013
Figure 8 8: Global - Temperature Sensitive Healthcare Products: Vaccines for Human Use: Export Volume Breakup by
Country (in %), 2013
14

15. Report Description and Highlights
Figure 8 9: Global - Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Export Volume Breakup by
Country (in %), 2013
Figure 8 10: Global - Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Export Volume
Breakup by Country (in %), 2013
Figure 8 11 : Global - Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic,
Prophylactic/Diagnostics Uses and Microbial Preparations: Export Volume Breakup by Country (in %), 2013
Figure 8 12: Global - Temperature Sensitive Healthcare Products: Insulin in Dosage: Export Volume Breakup by Country (in
%), 2013
Figure 8 13: Global - Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Export Volume Breakup by
Country (in %), 2013
Figure 8 14: Global - Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Export Volume
Breakup by Country (in %), 2013
Figure 8 15: Global - Imports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007 - 2013
Figure 8 16: Global - Imports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007 –
2013
Figure 8 17: Global - Imports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons),
2007 - 2013
Figure 8 18: Global - Imports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic,
Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007 - 2013
Figure 8 19 : Global - Imports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007 - 2013
Figure 8 20 : Global - Imports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007 -
2013
15

16. Report Description and Highlights
Figure 8 21: Global - Imports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in
Tons), 2007 - 2013
Figure 8 22: Global - Temperature Sensitive Healthcare Products: Vaccines for Human Use: Import Volume Breakup by
Country (in %), 2013
Figure 8 23: Global - Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Import Volume Breakup by
Country (in %), 2013
Figure 8 24: Global - Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Import Volume
Breakup by Country (in %), 2013
Figure 8 25 : Global - Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic,
Prophylactic/Diagnostics Uses and Microbial Preparations: Import Volume Breakup by Country (in %), 2013
Figure 8 26: Global - Temperature Sensitive Healthcare Products: Insulin in Dosage: Import Volume Breakup by Country (in
%), 2013
Figure 8 27: Global - Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Import Volume Breakup by
Country (in %), 2013
Figure 8 28: Global - Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Import Volume
Breakup by Country (in %), 2013
16

17. Report Description and Highlights
List of Tables
Table 3 1: Various Regulations on Healthcare Cold Chain Logistic Requirements
Table 4 1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
Table 4 2: Dry Ice Containers
Table 4 3: Refrigerated Shipping Containers with Gel Packs
Table 4 4: Costs Associated With the Cold Chain Shipment of Healthcare Products, 2015*
Table 4 5: Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2015
Table 5 1: Cold Chain Logistics: Comparison Matrix for Transport Modes
Table 6 1: Global - Healthcare Cold Chain Products Market - Breakup by Segment (in Billion US$), 2007 - 2014
Table 6 2: Global - Healthcare Cold Chain Products Market Forecast - Breakup by Segment (in Billion US$), 2015 - 2020
Table 6 3: Global - Biopharmaceutical Market - Sales by Class (in Billion US$), 2007 - 2014
Table 6 4: Global - Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2015 - 2020
Table 6 5: Stability of Various Biopharmaceuticals at Room Temperature
Table 6 6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 6 7: Temperature Stability of Commonly Used Vaccines
Table 6 8: The Effect of Temperature Excursions on the Usability of Vaccines
Table 6 9: Global - Major Vaccine Production Sites (in Numbers), 2008*
Table 6 10: Ideal Storage Temperatures for Clinical Trial Materials
Table 7 1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008 - 2010
17

18. To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/healthcare-cold-chain-logistics-market/
Contacts
7

19. © 2014 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.
19